January 9, 2011 – Korn/Ferry International/ has named Paul Pospisil Ph.D. as a senior client partner in the firm’s biotechnology and life sciences practice. He will be based out of the firm's New York office. Mr. Pospisil joins Korn/Ferry after serving more than 15 years as an investor and operating executive in the biotechnology industry. He brings experience in drug discovery and development, finance, business development, technology assessment and evaluation, and business strategy. "Paul's unique credentials as both an investor and biotechnology executive, coupled with his vast knowledge of the issues and trends driving the industry, will be a great fit for our entrepreneurial life sciences clients," said Stephen Israel, Korn/Ferry's managing director, biotechnology and pharmaceuticals.